Compare GROW & CTSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GROW | CTSO |
|---|---|---|
| Founded | 1968 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.7M | 29.3M |
| IPO Year | 1995 | 2008 |
| Metric | GROW | CTSO |
|---|---|---|
| Price | $2.97 | $0.38 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $5.38 |
| AVG Volume (30 Days) | 30.5K | ★ 248.3K |
| Earning Date | 05-11-2026 | 05-01-2026 |
| Dividend Yield | ★ 3.53% | N/A |
| EPS Growth | N/A | ★ 65.79 |
| EPS | ★ 0.27 | N/A |
| Revenue | ★ $23,850,609.00 | $22,503,908.00 |
| Revenue This Year | N/A | $10.34 |
| Revenue Next Year | N/A | $22.41 |
| P/E Ratio | $11.07 | ★ N/A |
| Revenue Growth | N/A | ★ 48.53 |
| 52 Week Low | $2.23 | $0.35 |
| 52 Week High | $3.65 | $1.22 |
| Indicator | GROW | CTSO |
|---|---|---|
| Relative Strength Index (RSI) | 52.11 | 41.13 |
| Support Level | $2.88 | $0.36 |
| Resistance Level | $3.26 | $0.73 |
| Average True Range (ATR) | 0.10 | 0.05 |
| MACD | -0.03 | 0.00 |
| Stochastic Oscillator | 26.97 | 15.34 |
US Global Investors Inc is a registered investment advisory firm. The company manages the following business segments: Investment management services; through which the company offers, to U.S. Global Investors Funds (USGIF or the Funds) and exchange-traded fund (ETF) clients, a range of investment management products and services to meet the needs of individual and institutional investors; and Corporate Investments, through which the company invests for its own account in an effort to add growth and value to its cash position. It derives all its revenue from Investment management services.
CytoSorbents Corp is a leader in blood purification for the treatment of life-threatening conditions in the intensive care unit and cardiac surgery. CytoSorbent's proprietary blood purification technologies are based on biocompatible, high-porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. CytoSorbent's technologies are used in several broad applications. Specifically, two important applications are: the removal of blood thinners during and after cardiothoracic surgery to reduce the risk of severe bleeding, and the removal of inflammatory agents and toxins in common critical illnesses that can cause massive inflammation, organ failure, and patient death. Geographically, in the USA, Germany, and Others.